Medilink North West News Spring 2014 | Page 6

EXPERT VIEW EMMA NOLAN LIVERPOOL JOHN MOORES UNIVERSITY Funding is the essential part of any start-up business or SMEs wanting to grow. Investment and financial backing is the cliff edge on which success lies. Here Emma Nolan, IP & Commercialisation Manager at the Research and Innovation Services department of Liverpool John Moores University explains the potential of SMEs being able to grow through crowdfunding. What is crowdfunding? This relatively new method of funding allows anyone – the ‘crowd’, to become an investor. It works on the principle of a large number of people each investing small amounts, in order to raise the necessary funds. Crowdfunding is growing exponentially – and is rapidly overtaking other sources of seed funding. Crowdcube, for instance (a crowdfunding website), secured nearly twice as many UK seed-stage equity deals as its nearest rival (Scottish co-investment fund) in 2013. It is stepping in to fill the equity funding gap for early-stage funding for SMEs and micro companies, left by Venture Capital as they move further to the later venture stages. Until now crowdfunding has perhaps been viewed as more relevant for retail and lifestyle opportunities. However it also lends itself equally well to high-tech opportunities needing seed funding to get started. A recent example is Pulmorphix, the first UK university spinout company to formally raise investment via equity crowd funding. Pulmorphix secured a TSB SMART award, pitched to traditional angel networks in order to get interest from ‘anchor angels’ and then launched an investment campaign via Crowdcube. Pulmorphix was seeking to raise £100,000 in return for 20% equity. They actually raised £125,000 in around 20 days via Crowdcube. The Pulmorphix technology is based on research from Liverpool John Moores University, which developed a